TrialTrials2018

A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.

Veronica Swystun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.